Search - tctmd.com

Displaying 1 - 20 of 134

Sort: Relevancy | Date

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

News Conference News CRT 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

L.A. McKeown

March 09, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News SCCT 2024

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Todd Neale

July 24, 2024

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Caitlin E. Cox

July 11, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

Advertisement

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

CVD Still the Leading Cause of Death and Disease Globally

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

FDA Approves Triple Therapy Polypill for High Blood Pressure

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Will Semaglutide Change Cardiac Surgery? It Already Has

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content